Apogee Therapeutics Analyst Ratings
Apogee Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Apogee Therapeutics (APGE) rating was a initiated with a price target of $0.00 to $29.00. The current price Apogee Therapeutics (APGE) is trading at is $20.50, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/08/2023 | 41.46% | Jefferies | → $29 | Initiates Coverage On | → Buy |
| 08/08/2023 | 41.46% | Guggenheim | → $29 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023/08/08 | 41.46% | 傑富瑞 | →$29 | 開始承保 | →購買 |
| 2023/08/08 | 41.46% | 古根海姆 | →$29 | 開始承保 | →購買 |
What is the target price for Apogee Therapeutics (APGE)?
Apogee Treeutics(APGE)的目標價格是多少？
The latest price target for Apogee Therapeutics (NASDAQ: APGE) was reported by Jefferies on August 8, 2023. The analyst firm set a price target for $29.00 expecting APGE to rise to within 12 months (a possible 41.46% upside). 2 analyst firms have reported ratings in the last year.
傑富瑞於2023年8月8日報道了Apogee治療公司(納斯達克：APGE)的最新目標價。這家分析公司將目標價定為29.00美元，預計APGE將在12個月內上漲(可能上漲41.46%)。去年有兩家分析公司公佈了評級。
What is the most recent analyst rating for Apogee Therapeutics (APGE)?
Apogee治療公司(APGE)的最新分析師評級是什麼？
The latest analyst rating for Apogee Therapeutics (NASDAQ: APGE) was provided by Jefferies, and Apogee Therapeutics initiated their buy rating.
阿波吉治療公司(納斯達克代碼：APGE)的最新分析師評級由傑富瑞提供，阿波吉治療公司啟動了他們的買入評級。
When is the next analyst rating going to be posted or updated for Apogee Therapeutics (APGE)?
Apogee Treeutics(APGE)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apogee Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apogee Therapeutics was filed on August 8, 2023 so you should expect the next rating to be made available sometime around August 8, 2024.
分析師在進行了廣泛的研究後得出股票評級，其中包括查閱公共財務報表，與Apogee Treeutics的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Apogee治療公司的上一次評級是在2023年8月8日提交的，因此您應該預計下一次評級將在2024年8月8日左右提供。
Is the Analyst Rating Apogee Therapeutics (APGE) correct?
分析師對Apogee Treeutics(APGE)的評級正確嗎？
While ratings are subjective and will change, the latest Apogee Therapeutics (APGE) rating was a initiated with a price target of $0.00 to $29.00. The current price Apogee Therapeutics (APGE) is trading at is $20.50, which is within the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Apogee Treateutics(APGE)評級是以0.00美元至29.00美元的目標價啟動的。目前Apogee Treateutics(APGE)的交易價格為20.50美元，在分析師的預測範圍內。